ID

11709

Descrição

The purpose of this study is to evaluate the safety of rivaroxaban in patients with recent acute coronary syndrome (ACS) and to assess the ability of rivaroxaban to reduce the occurrence of death, myocardial infarction (heart attack), repeat myocardial infarctions, stroke, and ischemia (inadequate blood supply to a local area) in patients with recent ACS. https://clinicaltrials.gov/ct2/show/NCT00402597

Link

https://clinicaltrials.gov/ct2/show/NCT00402597

Palavras-chave

  1. 28/07/2015 28/07/2015 -
Transferido a

28 de julho de 2015

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility ATLAS ACS TIMI 46 Acute Coronary Syndrome NCT00402597

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Descrição

Inclusion Criteria

Have symptoms suggestive of ACS that lasted at least 10 minutes at rest occurring within 7 days of randomization
Descrição

Have symptoms suggestive of ACS that lasted at least 10 minutes at rest occurring within 7 days of randomization

Tipo de dados

boolean

Alias
UMLS CUI-1
C0948089
diagnosis of ST-elevation myocardial infarction
Descrição

diagnosis of ST-elevation myocardial infarction

Tipo de dados

boolean

Alias
UMLS CUI-1
C1536220
diagnosis non-ST elevation myocardial infarction
Descrição

diagnosis non-ST elevation myocardial infarction

Tipo de dados

boolean

Alias
UMLS CUI-1
C3537184
diagnosis of unstable angina
Descrição

diagnosis of unstable angina

Tipo de dados

boolean

Alias
UMLS CUI-1
C0002965
Exclusion Criteria
Descrição

Exclusion Criteria

Active bleeding
Descrição

Active bleeding

Tipo de dados

boolean

Alias
UMLS CUI-1
C0019080
risk of bleeding
Descrição

risk of bleeding

Tipo de dados

boolean

Alias
UMLS CUI-1
C3251812
intracranial hemorrhage
Descrição

intracranial hemorrhage

Tipo de dados

boolean

Alias
UMLS CUI-1
C0151699
anticoagulant therapy
Descrição

anticoagulant therapy

Tipo de dados

boolean

Alias
UMLS CUI-1
C0150457
Significantly impaired renal function
Descrição

Significantly impaired renal function

Tipo de dados

boolean

Alias
UMLS CUI-1
C0035078
Significantly impaired hepatic function
Descrição

Significantly impaired hepatic function

Tipo de dados

boolean

Alias
UMLS CUI-1
C0085605
cardiogenic shock
Descrição

cardiogenic shock

Tipo de dados

boolean

Alias
UMLS CUI-1
C0036980
ventricular arrhythmias
Descrição

ventricular arrhythmias

Tipo de dados

boolean

Alias
UMLS CUI-1
C0085612

Similar models

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion Criteria
Acute coronary syndrome
Item
Have symptoms suggestive of ACS that lasted at least 10 minutes at rest occurring within 7 days of randomization
boolean
C0948089 (UMLS CUI-1)
STEMI
Item
diagnosis of ST-elevation myocardial infarction
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
diagnosis non-ST elevation myocardial infarction
boolean
C3537184 (UMLS CUI-1)
Unstable angina
Item
diagnosis of unstable angina
boolean
C0002965 (UMLS CUI-1)
Item Group
Exclusion Criteria
Hemorrhage
Item
Active bleeding
boolean
C0019080 (UMLS CUI-1)
Bleeding risk
Item
risk of bleeding
boolean
C3251812 (UMLS CUI-1)
intracranial hemorrhage
Item
intracranial hemorrhage
boolean
C0151699 (UMLS CUI-1)
anticoagulant therapy
Item
anticoagulant therapy
boolean
C0150457 (UMLS CUI-1)
Kidney failure
Item
Significantly impaired renal function
boolean
C0035078 (UMLS CUI-1)
Liver failure
Item
Significantly impaired hepatic function
boolean
C0085605 (UMLS CUI-1)
cardiogenic shock
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI-1)
ventricular arrhythmia
Item
ventricular arrhythmias
boolean
C0085612 (UMLS CUI-1)

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial